• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

Introduction to 6-(aminomethyl)piperidin-2-one;hydrochloride (CAS No: 118894-94-3)

6-(aminomethyl)piperidin-2-one;hydrochloride, identified by the Chemical Abstracts Service Number (CAS No) 118894-94-3, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the piperidine class of heterocyclic amines, characterized by a six-membered ring containing one nitrogen atom. The presence of an aminomethyl substituent at the 6-position and a carbonyl group at the 2-position, along with its hydrochloride salt form, imparts unique chemical and pharmacological properties that make it a valuable intermediate in drug development.

The aminomethyl group introduces a reactive amine functionality, which can participate in various chemical transformations such as condensation reactions, nucleophilic substitutions, and coupling reactions with other pharmacophores. This reactivity is particularly useful in medicinal chemistry for constructing more complex molecular architectures. The hydrochloride salt form enhances the solubility and stability of the compound, making it more suitable for pharmaceutical applications.

Recent advancements in drug discovery have highlighted the importance of piperidine derivatives due to their favorable pharmacokinetic profiles and biological activity. 6-(aminomethyl)piperidin-2-one;hydrochloride has garnered attention as a key intermediate in the synthesis of various therapeutic agents. Its structural features make it a versatile building block for designing molecules targeting different biological pathways.

In particular, the 6-(aminomethyl) moiety allows for facile introduction of additional functional groups, enabling the creation of libraries of compounds for high-throughput screening. This approach has been instrumental in identifying novel scaffolds with potential therapeutic efficacy. The compound’s ability to serve as a precursor for more complex molecules has been explored in several research studies.

One notable application of 6-(aminomethyl)piperidin-2-one;hydrochloride is in the development of kinase inhibitors. Kinases are enzymes involved in numerous cellular processes, and their dysregulation is associated with various diseases, including cancer. By incorporating this compound into drug candidates, researchers aim to modulate kinase activity effectively. The hydrochloride form ensures that the compound remains stable and bioavailable during formulation and administration.

Another area where this compound has shown promise is in the synthesis of central nervous system (CNS) drugs. Piperidine derivatives are known for their ability to cross the blood-brain barrier, making them suitable for treating neurological disorders. The aminomethyl group provides a site for further derivatization to enhance binding affinity and selectivity for specific CNS targets.

The chemical synthesis of 6-(aminomethyl)piperidin-2-one;hydrochloride involves multi-step reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include nucleophilic addition reactions to introduce the aminomethyl group followed by cyclization to form the piperidine ring. The final step typically involves conversion to the hydrochloride salt to improve stability and solubility.

Recent research has also explored catalytic methods for synthesizing this compound more efficiently. Transition metal-catalyzed reactions have been particularly effective in achieving regioselective modifications of the piperidine core. These advancements not only improve the scalability of production but also reduce environmental impact by minimizing waste generation.

In conclusion, 6-(aminomethyl)piperidin-2-one;hydrochloride (CAS No: 118894-94-3) is a versatile and important intermediate in pharmaceutical chemistry. Its unique structural features enable its use in synthesizing a wide range of therapeutic agents targeting various diseases. The ongoing research into its applications underscores its significance in modern drug development efforts.

• 130762-29-7(2-Piperidinone, 6-(aminomethyl)-)
• 814916-94-4(N-(piperidin-3-yl)butanamide)
• 1521412-60-1(5-amino-6-methylpiperidin-2-one)
• 2098107-90-3(5-Amino-6-methylpiperidin-2-one hydrochloride)
• 1235440-18-2(5-Aminopiperidin-2-one hydrochloride)
• 1003021-01-9((5R)-5-aminopiperidin-2-one hydrochloride)
• 27022-28-2((4aR,8aR)-rel-octahydro-1,5-Naphthyridine-2,6-dione)
• 1332765-67-9((S)-N-(Piperidin-3-yl)propanamide hydrochloride)
• 1286209-21-9((R)-N-(Piperidin-3-yl)propionamide hydrochloride)
• 672883-95-3((5S)-5-aminopiperidin-2-one hydrochloride)